Skip to main content

CORRECTION article

Front. Endocrinol., 26 August 2024
Sec. Cancer Endocrinology
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1466189

Corrigendum: Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer

This article is a correction to:

  1. Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer

    1. Read original article
Jingtao Sun&#x;Jingtao Sun1†Tian Tian&#x;Tian Tian2†Naiqiang WangNaiqiang Wang1Xuehui Jing,Xuehui Jing1,3Laiyuan QiuLaiyuan Qiu1Haochen CuiHaochen Cui1Zhao LiuZhao Liu1Jikai LiuJikai Liu1Lei YanLei Yan1Dawei Li*Dawei Li1*
  • 1Department of Urology, Qilu Hospital of Shandong University, Jinan, China
  • 2Respiratory and Critical Care Medicine Department, Qilu Hospital of Shandong University, Jinan, China
  • 3Department of Urology, Yucheng People’s Hospital, Dezhou, China

A Corrigendum on
Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer

By Sun J, Tian T, Wang N, Jing X, Qiu L, Cui H, Liu Z, Liu J, Yan L and Li D (2024). Front. Endocrinol. 15:1338420. doi: 10.3389/fendo.2024.1338420

In the published article, there was an error in the article type. Instead of “Review”, it should be “Original Research”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: serum sialic acid, bone metastases, prostate cancer, low-volume disease, high-volume disease

Citation: Sun J, Tian T, Wang N, Jing X, Qiu L, Cui H, Liu Z, Liu J, Yan L and Li D (2024) Corrigendum: Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer. Front. Endocrinol. 15:1466189. doi: 10.3389/fendo.2024.1466189

Received: 17 July 2024; Accepted: 23 July 2024;
Published: 26 August 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Sun, Tian, Wang, Jing, Qiu, Cui, Liu, Liu, Yan and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Dawei Li, lidaweimd@aliyun.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.